ArchiMed is an independant investment firm based in Lyon. It was founded in 2014 and acts as a strategic financial partner for European companies in the healthcare sector. ArchiMed has raised the small-cap funds Med I in 2014 (€146 million) and Med II in 2017 (€315 million), and has put together a 25-strong investment team.
In 2018, ArchiMed launched a new mid-cap investment vehicle called MED Platform I, which aims to accelerate the growth of European companies selected notably because of their potential to expand internationally and take part in sector consolidation. Med Platform I will invest between €50m and €300m in each of the 4 to 6 selected platform.
MED Platform I is managed by four partners: Denis Ribon, a well-known investor in the healthcare sector and co-founder of ArchiMed in 2014, Antoine Faguer, investor and entrepreneur, and Benoît Adelus and André-Michel Ballester, who have both successfully managed and developed several mid-cap healthcare companies.
In addition to MED Platform I, ArchiMed raised two small-cap funds totalling €461 million and set up an investment team of 25 people.
In 2018, FFP committed to invest up to €80 million in MED Platform I out of a target fund size of €800 million, with the potential to double its exposure by co-investing in companies of its choice, taking its maximum commitment to €160 million.
ArchiMed completed MED Platform I’s first close in October 2018, raising more than half of the fund’s target of €800 million.